The new study adds to growing evidence that measuring activated proteins is key to cancer therapy selection.Golden, CO, Feb. 10, 2025 (GLOBE ...

Peptides have gained significant attention in research due to their possible role in regulating various physiological ...

The oxytocin receptor (OXTR) is a G protein-coupled receptor with a diverse repertoire of intracellular signaling pathways, which are activated in response to binding oxytocin (OXT) and a similar ...

Among patients with advanced PIK3CA-mutated, HR-positive/HER2-negative breast cancer, Itovebi-based treatment generated ...

Exelixis, Inc. (NASDAQ:EXEL), a biopharmaceutical company with a market capitalization of $9.32 billion focused on developing and commercializing new medicines for difficult-to-treat cancers, has been ...

This combination has “the potential to become a new standard first-line treatment” for well-differentiated grade 1/2 gastroenteropancreatic neuroendocrine tumors with poor prognostic factors ...

Comparative outcomes of neuroendocrine tumors in the historically underserved population of Bronx, NY: Montefiore Einstein Comprehensive Cancer Center. Pamrevlumab ...

Third, activation of GPER-1 by molecules that mimic estrogen structure, such as xenoestrogens (e.g., Bisphenol A), poses a potential risk of endocrine disruption. Finally, the interaction of GPER-1 ...

Neuroendocrine diseases are disorders that affect the interaction between the nervous system and the endocrine system. Examples of diseases of neuroendocrine origin include diabetes insipidus ...

Researchers from Tel Aviv Sourasky Medical Center presented data from a study that aimed to investigate the genetic mechanisms underlying yellow nail syndrome (YNS), a rare disorder characterized by ...

GLP-1 agents may also suppress areas of the brain involved in impulse control and reward signaling, explaining some of the psychiatric benefits. They have anti-inflammatory properties and a ...